Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
11/2001
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound.
11/08/2001WO2001082923A1 Estrogen receptor modulators
11/07/2001EP1150967A1 Therapeutic compounds and methods
11/07/2001EP0925273B1 Pharmaceutical composition containing 4-oxo-butynic acids
11/07/2001CN1320599A Limited 9-cis-isotretinoins
11/06/2001US6313305 Cephalosporins
11/06/2001US6313170 For therapy of nutritional iron-deficiency anemia, blood loss anemia and hemolytic anemia in humans
11/06/2001US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/01/2001WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001WO2001081289A1 Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom
11/01/2001WO2001034548A3 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use
11/01/2001US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
10/2001
10/31/2001EP0782399B1 Hydroxycitric acid concentrate and method of making
10/31/2001DE10019861A1 Neues Synthesezwischenprodukt, seine mikrobiologische Herstellung und Verwendung zur Synthese von Vitamin D-Derivaten A new synthetic intermediate, its microbiological production and use for the synthesis of vitamin D derivatives
10/31/2001DE10014922A1 New neocarboxylic acids useful for producing compositions, especially lubricants and pressure transmission agents, comprise fatty acids and/or derivatives with acyloxylated double bond(s)
10/31/2001CN1320111A Method for preparing p-hydroxymandelic compounds optically substituted
10/30/2001US6310244 Photocleavable and acid cleavable linkers for combinatorial chemistry
10/25/2001WO2001079165A1 Synthesis intermediate products for producing vitamin d derivatives
10/25/2001WO2001034546A3 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
10/25/2001US20010034448 New compounds, their preparation and use
10/24/2001EP1148042A2 Method for producing optically and chemically pure (R)- and (S)-hydroxycarboxylic acids
10/24/2001EP1147167A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
10/24/2001EP0900190B1 Novel acetals of hydroxy carboxylic acids, derivatives thereof and process for the preparation thereof
10/23/2001US6307094 Process for substituted 3-hydroxybutyrate esters
10/23/2001US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001US6307080 Water-soluble zinc pyruvates or their hydrates, method for the product ion thereof and their use
10/23/2001US6307072 Oxidizing an olefin, an alcohol, or an aldehyde in the presence of a catalyst formed of a polyoxo metalate substituted with a divalent transition metal cation.
10/23/2001US6307044 Process for the preparation of macrocyclic metalloprotease inhibitors
10/23/2001US6306907 Antipsychotic
10/18/2001WO2001077371A1 Preincubation assay method
10/18/2001US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001US20010031882 Lipoxin compounds and their use in treating cell proliferative disorders
10/18/2001US20010031786 Antidiabetic agents, obesity
10/18/2001US20010031766 Prostaglandin receptor ligands
10/18/2001US20010031764 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/18/2001US20010031762 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/18/2001US20010031489 Synthesis and isolation of polylactone polyester biopolymers from recombinant bacteria comprising fragment of poly (hydroxy fatty acid) synthase from Thiocapsa incubated with carbon source
10/18/2001CA2389691A1 A pre-incubation method for an assay of an inhibitor to an hcv rna-dependent rna polymerase
10/17/2001EP1144718A1 Indium source reagent compositions
10/17/2001EP1144382A2 Process for preparing 1,5-diaryl-3-substituted pyrazoles
10/17/2001EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/17/2001CN1318047A Process for preparing carboxylic acids
10/17/2001CN1317478A Pure beta-hydroxyethoxyacetic acid salt, pure 2-p-dioxaneone, and prodn. method thereof
10/17/2001CN1073066C Process for improving purity of hexane diol-1, 6
10/17/2001CA2344004A1 Process for the preparation of optically and chemically highly pure (r)- or (s)-a-hydroxycarboxylic acids
10/16/2001US6303785 Substituted n-cyclopropyltetrahydroisoquinolines
10/16/2001US6303351 Generating preferential compound; feed bioreator oxygen, carbon source and nitrogen source, ferment, continuously withdraw fermentation product and recover preferential compound
10/11/2001US20010029256 Peroxisome proliferator activator receptor; dietetics, antidiabetic agents
10/10/2001EP1140799A1 Novel propargylether derivatives
10/09/2001US6300376 Indane dimer compounds and their pharmaceutical use
10/09/2001CA2123223C Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/04/2001WO2001072678A1 Phenol derivatives, process for preparation of the same and use thereof
10/04/2001US20010027214 Stable and nonhygroscopic salts to form tablets, capsules, powders, etc. suitable for dietary/nutritional humans supplements and a feed supplement for veterinary medicine; high-energy metabolism; cardiovascular systems
10/04/2001US20010027172 Made by decarboxylation of the corresponding fluoroalkyl ether carboxylic acids; use in fluorinated polyether deposition, soldering, and cleaning and drying; low boiling, shorter atomospheric life, less harmful to ozone layer
10/04/2001EP1138664A2 Purified salt of B-hydroxyethoxy acetic acid, 2-P-dioxanone, and manufacturing method therefor
10/02/2001US6297399 Hypotensive agents
09/2001
09/27/2001WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
09/27/2001WO2001070176A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light
09/27/2001WO2001010885A3 Birch bark processing and the isolation of natural products from birch bark
09/27/2001US20010025112 Using solvent mixture of ether and hydrocarbon
09/27/2001US20010025084 Photocleavable and acid cleavable linkers for combinatorial chemistry
09/27/2001CA2401728A1 Difluorobutyric acid metalloprotease inhibitors
09/26/2001EP1135119A1 Glucose and lipid lowering compounds
09/25/2001US6294069 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
09/20/2001WO2001068582A1 Novel fatty acid analogous
09/20/2001DE10013578A1 Use of 3,4-dihydroxymandelic acid and/or stereoisomers as antioxidants and/or radical scavengers in protecting mammalian skin, cosmetic or pharmaceutical preparations, foodstuffs, lacquers and polymers
09/19/2001EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
09/19/2001EP0612244B1 Endothelin receptor antagonists
09/19/2001CN1071305C Preparation of linear chain omega-formyl pentanoic acid or correspondant linear chain formyl nitrile compounds
09/19/2001CN1071302C Process to prepare 5-formylvaleric acid
09/18/2001US6291677 Compounds having activity as inhibitors of cytochrome P450RAI
09/13/2001WO2001066508A2 Process for the recovery of organic acids from aqueous solutions
09/13/2001US20010021791 Cyclopropyl phenyl ketone compound
09/13/2001US20010021785 Indium source reagent compositions, and use thereof for deposition of indium-containing films on substrates and ion implantation of indium-doped shallow junction microelectronic structures
09/12/2001CN1070841C Carboxylic acid derivatives, their preparation and their use
09/12/2001CN1070836C Method for preparing sodium ferulate and sterol using ferulates by water separation method
09/11/2001US6288244 Process for the preparation of 3, 4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars
09/06/2001US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/05/2001EP0738253B1 Carbonyl containing compounds
09/05/2001CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
09/04/2001US6284904 Purification of organic acids using anion exchange chromatography
08/2001
08/30/2001WO2001004323A3 11-arachidonate-lipoxygenase mutants
08/30/2001US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
08/30/2001US20010018043 Sorbitol esters obtained by esterinterchange og oxyalkylated sorbitol with fatty acid methylester or triglycerides; solubilizers of perfume oils; taste; dentrifices
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP1127043A1 Stereoselective process for preparing (cyclo)alkyl phenylglycolic acids
08/29/2001EP0809622B1 Anti-inflammatory benzoic acid derivatives
08/28/2001US6281391 Reacting hydroxyamide compound with lithiating agent comprising 4-methylthiophenyllithium in non-reacting solvent to form methylthiophenyl-hydroxyketone compound
08/28/2001CA2089566C Manufacture of neopentyl glycol (iia)
08/23/2001WO2001060778A2 Aspirin-triggered lipid mediators
08/23/2001US20010016665 Condensing isovaleraldehyde with methyldiester compound to form an intermediate, reacting the product with cyanide souce to form cyanide derivative of diesters, decarboxylation and then hydrolysis with a metal hydroxide and hydrogenation
08/22/2001EP1125914A1 Process for separating and purifying eicosapentaenoic acid or its ester
08/22/2001EP1124798A1 Synthesis of methylthiophenyl hydroxyketones
08/22/2001EP1124785A1 A process for the preparation of alpha-arylalkanoic acids
08/22/2001EP1124782A1 Method for racemate splitting of 2-hydroxypropionic acids
08/22/2001CN1309559A Synthetically prepared hydroxy citric acid composition for treatment and/or propylaxis of overweight and use thereof
08/21/2001US6277782 Chiral adsorbents and preparation thereof as well as compounds on which the adsorbents are based and preparation of these compounds
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 147